Literature DB >> 23569777

Association of ABO blood group and Plasmodium falciparum malaria in Dore Bafeno Area, Southern Ethiopia.

Tewodros Zerihun1, Abraham Degarege, Berhanu Erko.   

Abstract

OBJECTIVE: To assess the distribution of ABO blood group and their relationship with Plasmodium falciparum (P. falciparum) malaria among febrile outpatients who sought medical attention at Dore Bafeno Health Center, Southern Ethiopia.
METHODS: A total of 269 febrile outpatients who visited Dore Bafeno Health Center, Southern Ethiopia, were examined for malaria and also tested for ABO blood groups in January 2010. The blood specimens were collected by finger pricking, stained with Geimsa, and examined microscopically. Positive cases of the parasitemia were counted. CareStart™ Malaria Pf/Pv Combo was also used to test the blood specimens for malaria. ABO blood groups were determined by agglutination test using ERYCLONE(®) antisera. Data on socio-demographic characteristics and treatment status of the participants were also collected. Chi-square and ANOVA tests were used to assess the difference between frequencies and means, respectively.
RESULTS: Out of a total of 269 participants, 178 (66.2%) febrile patients were found to be infected with Plasmodium parasites, among which 146 (54.3%), 28 (10.4%), and 4 (1.5%) belonged to P. falciparum, P. vivax, and mixed infections, respectively. All febrile patients were also tested for ABO blood groups and 51.3%, 23.5%, 21.9% and 3.3% were found to be blood types of O, A, B and AB, respectively. Both total malaria infection and P. falciparum infection showed significant association with blood types (P<0.05). The proportion of A or B but not O phenotypes was higher (P<0.05) in individuals with P. falciparum as compared with non-infected individuals. The chance of having P. falciparum infection in patients with blood groups A, B and AB was 2.5, 2.5 and 3.3 times more than individuals showing blood O phenotypes, respectively. The mean P. falciparum malaria parasitaemia for blood groups A, B, AB, and O were 3 744/µL, 1 805/µL, 5 331/µL, and 1 515/µL, respectively (P<0.01).
CONCLUSIONS: The present findings indicate that individuals of blood groups A, B and AB are more susceptible to P. falciparum infection as compared with individuals of blood group O. Nevertheless, further in depth studies are required to clearly establish the role that ABO blood group plays in P. falciparum malaria.

Entities:  

Keywords:  ABO blood groups; Agglutination test; Association; Blood specimen; CareStart™ Malaria Pf/Pv Combo; Distribution; ERYCLONE® antisera; Ethiopia; Febrile outpatient; Geimsa; Malaria infection; Parasitemia; Plasmodium falciparum malaria; Plasmodium parasite; Plasmodium vivax

Mesh:

Substances:

Year:  2011        PMID: 23569777      PMCID: PMC3614231          DOI: 10.1016/S2221-1691(11)60045-2

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  45 in total

1.  Evidence for an expression of blood group A antigen on platelet glycoproteins IV and V.

Authors:  D Stockelberg; M Hou; L Rydberg; J Kutti; H Wadenvik
Journal:  Transfus Med       Date:  1996-09       Impact factor: 2.019

2.  ABO blood groups and infections with human malarial parasites in vivo and in vitro.

Authors:  J O Osisanya
Journal:  East Afr Med J       Date:  1983-09

3.  P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1.

Authors:  J A Rowe; J M Moulds; C I Newbold; L H Miller
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

Review 4.  Molecular aspects of severe malaria.

Authors:  Q Chen; M Schlichtherle; M Wahlgren
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

5.  Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting.

Authors:  J Alexandra Rowe; Ian G Handel; Mahamadou A Thera; Anne-Marie Deans; Kirsten E Lyke; Abdoulaye Koné; Dapa A Diallo; Ahmed Raza; Oscar Kai; Kevin Marsh; Christopher V Plowe; Ogobara K Doumbo; Joann M Moulds
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-24       Impact factor: 11.205

6.  Blood groups and malaria.

Authors:  F Montoya; M Restrepo; A E Montoya; W Rojas
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1994 Jan-Feb       Impact factor: 1.846

Review 7.  Malaria and the red cell.

Authors:  David J Weatherall; Louis H Miller; Dror I Baruch; Kevin Marsh; Ogobara K Doumbo; Climent Casals-Pascual; David J Roberts
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2002

8.  Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation.

Authors:  J Carlson; G B Nash; V Gabutti; F al-Yaman; M Wahlgren
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

Review 9.  The ABO blood group system and Plasmodium falciparum malaria.

Authors:  Christine M Cserti; Walter H Dzik
Journal:  Blood       Date:  2007-05-14       Impact factor: 22.113

10.  Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria.

Authors:  Andrew E Fry; Michael J Griffiths; Sarah Auburn; Mahamadou Diakite; Julian T Forton; Angela Green; Anna Richardson; Jonathan Wilson; Muminatou Jallow; Fatou Sisay-Joof; Margaret Pinder; Norbert Peshu; Thomas N Williams; Kevin Marsh; Malcolm E Molyneux; Terrie E Taylor; Kirk A Rockett; Dominic P Kwiatkowski
Journal:  Hum Mol Genet       Date:  2007-11-13       Impact factor: 6.150

View more
  12 in total

1.  Genotyping of ABO and Duffy blood groups among malaria patients in Thailand.

Authors:  Phattharaphon Hongfongfa; Jiraporn Kuesap
Journal:  J Parasit Dis       Date:  2021-08-11

2.  Burden of malaria infection among individuals of varied blood groups in Kenya.

Authors:  Redemptah Yeda; Charles Okudo; Eunice Owiti; Gladys Biwot; Cliff Momanyi; Winnie Korir; Thoya Mitsanze; Caroline Tegerei; Dennis Juma; Benjamin Opot; Edwin Mwakio; Gladys Chemwor; Raphael Okoth; Douglas O Ochora; Agnes C Cheruiyot; Amanda Roth; Hoseah M Akala; Ben Andagalu
Journal:  Malar J       Date:  2022-09-01       Impact factor: 3.469

3.  Prevalence and association of malaria with ABO blood group and hemoglobin level in individuals visiting Mekaneeyesus Primary Hospital, Estie District, northwest Ethiopia: a cross-sectional study.

Authors:  Belaynesh Tazebew; Abaineh Munshea; Endalkachew Nibret
Journal:  Parasitol Res       Date:  2021-03-03       Impact factor: 2.289

4.  The genetic control of immunity to Plasmodium infection.

Authors:  Audrey V Grant; Christian Roussilhon; Richard Paul; Anavaj Sakuntabhai
Journal:  BMC Immunol       Date:  2015-03-26       Impact factor: 3.615

5.  Relative Susceptibilities of ABO Blood Groups to Plasmodium falciparum Malaria in Ghana.

Authors:  Richmond Afoakwah; Edmond Aubyn; James Prah; Ekene Kwabena Nwaefuna; Johnson N Boampong
Journal:  Adv Hematol       Date:  2016-02-15

6.  Assessing ABO/Rh Blood Group Frequency and Association with Asymptomatic Malaria among Blood Donors Attending Arba Minch Blood Bank, South Ethiopia.

Authors:  Getaneh Alemu; Mohammedaman Mama
Journal:  Malar Res Treat       Date:  2016-01-27

7.  High rhesus (Rh(D)) negative frequency and ethnic-group based ABO blood group distribution in Ethiopia.

Authors:  Lemu Golassa; Arega Tsegaye; Berhanu Erko; Hassen Mamo
Journal:  BMC Res Notes       Date:  2017-07-26

8.  Relationship between Malaria and ABO Blood Types in East China.

Authors:  Xuan Zhang; Meifang Yang; Hong Zhao; Jianhua Hu; Lanjuan Li
Journal:  Biomed Res Int       Date:  2017-11-07       Impact factor: 3.411

9.  A study on the prevalence of dog erythrocyte antigen 1.1 and detection of canine Babesia by polymerase chain reaction from apparently healthy dogs in a selected rural community in Zimbabwe.

Authors:  Solomon Dhliwayo; Tariro A Makonese; Belinda Whittall; Silvester M Chikerema; Davies M Pfukenyi; Musavenga T Tivapasi
Journal:  J S Afr Vet Assoc       Date:  2016-10-26       Impact factor: 1.474

Review 10.  ABO histo-blood group and risk of respiratory atopy in children: a review of published evidence.

Authors:  Samuel N Uwaezuoke; Joy N Eze; Adaeze C Ayuk; Ikenna K Ndu
Journal:  Pediatric Health Med Ther       Date:  2018-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.